Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Apitope starts new clinical trial of its investigational Multiple Sclerosis treatment
'Green Mice' display limitations in enhanced green fluorescent protein expression in retina and optic nerve cells.
Multiple sclerosis coexisting with spinal cord ependymoma: a case report.
Mind-body medicine for multiple sclerosis: a systematic review.
Piet Mondrian's trees and the evolution in understanding multiple sclerosis, Charcot Prize Lecture 2011.
Transverse myelitis in Behçet's disease: a series of 4 cases and review of the literature.
Platelets and neurovascular inflammation.
Methodology of an International Study of People with Multiple Sclerosis Recruited through Web 2.0 Platforms: Demographics, Lifestyle, and Disease Characteristics.
Role of Immunosuppressive Therapy for the Treatment of Multiple Sclerosis.
Macrophages in inflammatory multiple sclerosis lesions have an intermediate activation status.
Relationship of UV exposure to prevalence of multiple sclerosis in England.
Mortality and Cause of Death in Multiple Sclerosis: Findings from a Prospective Population-Based Cohort in Bizkaia, Basque Country, Spain.
Safety profile of dalfampridine extended release in multiple sclerosis: 5-year postmarketing experience in the United States.
[The role of dopamine in the regulation of the interaction between nervous and immune systems in multiple sclerosis.]
[Pharmacological treatment of spasticity in multiple sclerosis].
Dementia in multiple sclerosis: Report of a case with cortical gray matter involvement and frontotemporal-like clinical features.
Microstructural magnetic resonance imaging of cortical lesions in multiple sclerosis.
Clostridia as agents of zoonotic disease.
Persistent Inflammation in the CNS during Chronic EAE Despite Local Absence of IL-17 Production.
LOGISMOS-B: Layered Optimal Graph Image Segmentation of Multiple Objects and Surfaces for the Brain.
The utility of the Six-Spot Step Test as a measure of walking performance in ambulatory individuals with Multiple Sclerosis across the disability spectrum.
[Diffusion-tensor magnetic resonance tomography and tractography in multiple sclerosis: a review].
Correction: Correlation of Diffusion and Metabolic Alterations in Different Clinical Forms of Multiple Sclerosis.
Post-infective transverse myelitis following Streptococcus pneumoniae meningitis with radiological features of acute disseminated encephalomyelitis: a case report.
Anti-CD25 Immunotherapy: Regulating the Regulators.
Pages
« first
‹ previous
…
287
288
289
290
291
292
293
294
295
…
next ›
last »